【摘要】目的评价维持性血液透析(maintenance hemodialysis,MHD)患者甲状旁腺切除术后营养不良炎症状态。方法选择MHD 患者甲状旁腺切除患者23 例，观察术后12 月干体质量、血钙、血磷、全段甲状旁腺激素(intact parathyroid hormone,iPTH)、血红蛋白、红细胞比容、血清白蛋白、总铁结合力、以及营养不良-炎症评分(malnutrtion-inflammation score，MIS)的变化；并观察血清C 反应蛋白(Creactive protein，CRP)、白细胞介素-6(interleukin-6,IL-6)、肿瘤坏死因子(tumor necrosis factor, TNF-a)水平变化。结果与手术前比较，术后12 月干体质量增加[(52.2±5.4) 比 (57.5±6.6)kg，t=-2.964, P=0.005]；血红蛋白明显增加[(89.5±8.3)比(102.5± 7.1)g/L, t=-5.716, P＜0.001]；红细胞比容明显增加[(31.1±3.1)比(38.7±4.1)%, t=-6.975, P＜0.001]；血清白蛋白明显增加[(31.2± 4.2)比(40.2±4.7)g/L，t=-6.865, P＜0.001]；钙、磷和iPTH 水平明显下降[(2.85±0.17)比(2.10±0.42)mmol/L, t=7.871, P＜0.001；(1.99±0.26)比(1.13±0.17)mmol/L，t=13.432，P＜0.001；(1536.0±252.0)比(144.4±41.9)ng/L，t=26.136，P＜0.001]；术后12 月CRP、IL- 6 和TNF-α 水平均明显下降[(10.2±1.8)比(4.1±1.2)ng/dl，t=13.583，P＜0.001；(65.8±16.7)比(42.6±13.9)pg/ml，t= 5.125，P＜0.001；(49.6±13.7)比(34.6±8.5)pg/ml，t=4.468，P＜0.001]；MIS 评分程度降低[(11.80±2.43)比(6.35±2.50)分，t= 7.480，P＜0.001]。结论甲状旁腺全切手术能有效改善维持性透析患者的营养不良和炎症状态，营养不良和炎症状态改善可能是继发性甲状旁腺功能亢进患者生存质量改善的机制之一。
【Abstract】Objective Evaluation of malnutrition and inflammation after parathyroidectomy in 23 patients with maintenance hemodialysis(MHD). Methods 23 MHD patients with parathyroidectomy were enrolled. Then, we observed the changes of dry weight, serum calcium, phosphate, intact parathyroid hormone (iPTH), hemoglobin, hematocrit, serum albumin, total iron binding capacity, and Malnutrtion- inflammation score (MIS) was calculated at 12 months after parathyroidectomy. Results Compared with condition before parathyroidectomy, patients’dry weight, hemoglobin, hematocrit and serum albumin increased significantly at 12 months after parathyroidectomy [(52.2±5.41)kg vs.(57.5±6.6)kg, t=-2.964, P=0.005;(89.5±8.3)g/L vs.(102.5±7.1)g/L, t=- 5.716, P=0.000; (31.1±3.1)% vs. (38.7±4.1)%, t=- 6.975, P＜0.001; (31.2±4.2)g/L vs. (40.2±4.7)g/L, t=-6.865, P=0.000]. The levels of calcium, phosphate and iPTH decreased significantly [(2.85±0.17) vs. (2.10±0.42)mmol/L, t=7.871, P＜0.001; (1.99±0.26) vs. (1.13±0.17)mmol/L, t=13.432, P＜0.001;(1536.0±252.0) vs. (144.4±41.9)ng/L, t=26.136, P＜0.001]. Meanwhile, the level of C-reactive protein (CRP), interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α) and MIS decreased significantly at 12 months after parathyroidectomy [(10.2±1.8)ng/dl vs. (4.1±1.2)ng/dl, t=13.583, P＜0.001; (65.8±16.7) pg/ml vs. (42.6±13.9)pg/ml, t=5.125, P＜0.001; (49.6±13.7)pg/ml, vs. (34.6±8.517)pg/ml, P＜0.001; (11.80±2.43)scores vs. (6.35±2.50)scores, t=7.480, P＜0.001). Conclusion Total parathyroidectomy can effectively improve the status of malnutrition and inflammation in MHD patients. Further, these will be beneficial to improve the quality of life in MHD patients with secondary hyperparathyroidism.
1. Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group.Clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease–mineral and bone disorder (CKD-MBD). Kidney Int,2017,Suppl 7:1–59.
2. Block GA, Klassen PS, Lazarus JM ,et al. Mineral metabo-lism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol,2004,15:2208-2218.
3. Msaad R, Essadik R, Mohtadi K,et al. Predictors of mortality in hemodialysis patients.Pan Afr Med J, 2019,28;33:61.
4. Lau WL, Obi Y, Kalantar-Zadeh K. Parathyroidectomy in the Management of Secondary Hyperparathyroidism.Clin J Am Soc Nephrol,2018,13(6):952-961.
5. Schneider R, Slater EP, Karakas E, et al.Initial parathyroid surgery in 606 patients with renal hyperpar-athyroidism. World J Surg,2012,36(2):318-326.
6. Iwamoto N, Sato N, Nishida M, Hashimoto T,et al，Low Parathyroid Hormone Levels After Parathyroidectomy Reduce Cardiovascular Mortality in Chronic Hemodialysis Patients.Clin Exp Nephrol，2016,20(5):808-814.
7. Blumberg Benyamini S, Katzir Z, Biro A, et al. Nutrition assessment and risk prediction in dialysis patients-a new integrative score. J Ren Nutr, 2014,24:401–410.
8. Kalantar-Zadeh K,Ikizler TA, Block G, et al. Malnutrition-inflflammation complex syndrome in dialysis patients: causes and consequences, Am. J. Kidney Dis, 2003,42(5):864–881.
9. Kalantar-Zadeh K, Kopple JD, Block G,et al. A malnutrition–inflammation score is correlated with morbidity and mortality in maintenance hemodialysis patients.Am J Kidney Dis,2001,38:1343–1350.
10. Kir S, Komaba H, Garcia AP et al. PTH/PTHrP receptor mediates cachexia in models of kidney failure and cancer Cell Metab,2016,23:315–323.
11. Kir S, White JP, Kleiner S，et al. Tumour-derived PTH-related protein triggers adipose tissue browning and cancer cachexia.Nature,2014,513:100–104.
12. Isakova T, Wahl P, Vargas G，et al. Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease.Kidney Int,2011,79:1370–1378.
13. Lavi-Moshayoff V, Wasserman G, Meir T,et al. PTH increases FGF23 gene expression and mediates the high-FGF23 levels of experimental kidney failure: a bone parathyroid feedback loop.Am J Physiol Renal Physiol,2010,299:F882–889.
14. Faul C, Amaral AP, Oskouei B ,et al. FGF23 induces left ven-tricular hypertrophy.J Clin Invest,2011,121:4393–408.
15. Grabner A, Amaral AP, Schramm K，et al. Activation of car-diac fibroblast growth factor receptor 4 causes left ventricular hypertrophy.Cell Metab,2015,22:1020–1032.
16. Rossaint J,Oehmichen J, Van Aken H,et al. FGF23 signaling impairs neutrophil recruitment and host defense during CKD. J Clin Invest,2016,126:962–74.doi;10.1172/CI83470.
17. Singh S, Grabner A, Yanucil C, et al. Fibroblast growth factor directly targets hepatocytes to promote inflammation in chronic kidney disease.Kidney Int,2016,90:985–996.
18. Ikizler TA, Cano NJ, Franch H, et al Prevention and treat-ment of protein energy wasting in chronic kidney disease patients: a consensus statement by the International Society of Renal Nutrition and Metabolism.Kidney Int,2013,84:1096–1107.
19. Carrero JJ, Stenvinkel P, Cuppari L, et al.Etiology of the protein-energy wasting syndrome in chronic kidney disease: a con-sensus statement from the International Society of Renal Nutrition and Metabolism (ISRNM).J Ren Nutr,2013,23:77–90.
20. Ogawa K, Sanada K, MacHida S, et al. Resistance exercise training-induced muscle hypertrophy was associated with reduc-tion of inflammatory markers in elderly women. Mediat Inflamm,2010,171023.
21. Cuppari L, de Carvalho AB, Avesani CM, et al. Increased resting energy expenditure in hemodialysis patients with severe hyperparathyroidism. J Am Soc Nephrol,2004,15:2933–2939
22. Iwamoto N, Sato N, Nishida M,et al.Total parathyroidectomy improves survival of hemodialysis patients with secondary hyperparathyroidism.J Nephrol. 2012,25(5):755-763.
23. Günther T, Chen ZF, Kim J,et al. Geneticablation of parathyroid glands reveals another source of parathyroid hormone.Nature,2000,406:199–203.
